Solta Medical Inc. (SLTM)

2.92
0.00 (0.00)
Prev Close 2.92
Open 2.92
Day Low/High 2.92 / 2.93
52 Wk Low/High 1.44 / 2.99
Volume 1.01M
Avg Volume 1.53M
Exchange
Shares Outstanding 81.53M
Market Cap 238.06M
EPS -0.59
Div & Yield N.A. (N.A)

Latest News

Stocks Under $10 Weekly Summary

During a topsy-turvy week of trading, we initiated a model portfolio position, added to one name and booked some gains in another.

Stocks Under $10 Weekly Summary

We used the action this week to book some profits in oen model portfolio name and we believe that trading volume will pick up again next week.

Stocks Under $10 Weekly Summary

We did not make any trades during this holiday-shortened week, but one of our goals for 2014 is to introduce some new names to the model portfolio.

Stocks Under $10 Weekly Summary

This week, we booked profits in one model portfolio position that had huge gains and sold most of a holding that received a takeover bid.

SHAREHOLDER ALERT: Law Office Of Brodsky & Smith, LLC Announces Investigation Of Solta Medical, Inc.

SHAREHOLDER ALERT: Law Office Of Brodsky & Smith, LLC Announces Investigation Of Solta Medical, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Solta Medical, Ltd.

SOLTA MEDICAL INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Solta Medical, Inc. (SLTM) Over The Proposed Sale Of The Company To Valeant Pharmaceuticals (VRX)

SOLTA MEDICAL INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Solta Medical, Inc. (SLTM) Over The Proposed Sale Of The Company To Valeant Pharmaceuticals (VRX)

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Solta Medical, Inc.

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Solta Medical, Inc. Stockholders

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Solta Medical, Inc. Stockholders

Kirby McInerney LLP is investigating potential claims against the Board of Directors of Solta Medical, Inc.

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout Of Solta Medical, Inc.

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout Of Solta Medical, Inc.

The law firm of Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Solta Medical, Inc.

Valeant (VRX) To Buy Solta Medical (SLTM) For $236 Million in Cash

Valeant (VRX) To Buy Solta Medical (SLTM) For $236 Million in Cash

Valeant Pharmaceuticals (VRX) will buy Solta Medical (SLTM) for $2.92 per share in cash.

SOLTA MEDICAL INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Solta Medical, Inc. (SLTM) Over The Proposed Sale Of The Company To Valeant Pharmaceuticals (VRX)

SOLTA MEDICAL INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Solta Medical, Inc. (SLTM) Over The Proposed Sale Of The Company To Valeant Pharmaceuticals (VRX)

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Solta Medical, Inc.

Locking In Gains in Solta Medical

We are selling the bulk of our position on news that the company is being acquired by another pharmaceutical name.

Solta Medical Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Valeant Pharmaceuticals

Solta Medical Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Valeant Pharmaceuticals

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Solta...

Stocks Under $10 Weekly Summary

Though the market began the week by selling off, it managed to rebound and we used the volatility to add to one of our model portfolio positions.

4 Health Care Stocks Under $10 to Watch

4 Health Care Stocks Under $10 to Watch

Keep these under-$10 stocks on your radar.

Stocks Under $10 Weekly Summary

We took advantage of the market's volatility this week to add a new name to the model portfolio and make a few other adjustments.

Stocks Under $10 Weekly Summary

We pocketed some gains in one model portfolio position this week and used the proceeds to add to another holding.

Stocks Under $10 Weekly Summary

As earnings season came to a close this week, we used post-reporting weakness to add to one of our model portfolio positions.

Solta Medical, Unilife Trading Higher

Both companies announced quarterly results overnight and we are maintaining our Two rating on each stock.

Stocks Under $10 Weekly Summary

We took advantage of the volatility this week to add to three of our model portfolio positions and we took profits in another holding.

Stocks Under $10 Weekly Summary

U.S. stocks took a breather this week and we took advantage of the selloff to add shares to two of our model portfolio positions.

Adding Shares on Weakness

This medical equipment name is trading lower this week on fears of increased competition for its services.

Stocks Under $10 Weekly Summary

With earnings season in full swing, trading remained volatile this week and we added shares to two model portfolio positions and trimmed three others.

Stocks Under $10 Weekly Summary

As the market celebrated the end of the government shutdown this week, we booked some profits in two positions and added shares to another holding.

Stocks Under $10 Weekly Summary

We used the volatility this week to add shares to four model portfolio positions and we also trimmed one holding.

Stocks Under $10 Weekly Summary

We made no changes to the model portfolio this week, which saw the volatile markets end higher despite the government shutdown.